APEN
Apollo Endosurgery Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Market Cap: 580 Million
Primary Exchange: NASDAQ
Website: apolloendo.com
Shares Outstanding: 58 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.7588307178179357
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 2828 trading days
From: 2013-07-31 To: 2023-04-03
Lowest Point:
Apollo Endosurgery Announces US Labeling Update on the ORBERA® Intragastric Balloon System
via: Business Wire at 2019-06-13 12:02:00:000
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that it has received FDA approval for its proposed labeling updates for the ORBERA Intragastric Balloon System… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-12-30 | 5.5 | 1.0 | 5.5 | |||
| 2016-06-13 | 14.0 | 1.0 | 14.0 |